Skip to main content
HOSHIIRYO-SANKI CO., LTD. logo

HOSHIIRYO-SANKI CO., LTD. — Investor Relations & Filings

Ticker · 7634 ISIN · JP3845750003 T Human health and social work activities
Open in API
Filings indexed 70 across all filing types
Latest filing 2026-05-19 Regulatory Filings
Country JP Japan
Listing T 7634

About HOSHIIRYO-SANKI CO., LTD.

https://www.hosi.co.jp/

HOSHIIRYO-SANKI CO., LTD. is a specialized manufacturer and supplier of pharmaceutical medical gases, including oxygen, nitrous oxide, nitrogen, and carbon dioxide. The company's operations are centered around two main business areas: medical gas and home medical care. The medical gas segment involves the production and supply of gases to healthcare facilities, along with the maintenance of related equipment. The home medical care segment provides comprehensive support for patients requiring therapies such as Home Oxygen Therapy (HOT), Continuous Positive Airway Pressure (CPAP), and Home Mechanical Ventilation (HMV). The company also engages in the nursing care and welfare equipment business, supported by a 24-hour, year-round service infrastructure.

Recent filings

Filing Released Lang Actions
（訂正）「当社株式等の大規模買付行為等への対応方針（買収への対応方針）の導入に関するお知らせ」の一部訂正について
Regulatory Filings Classification · 91% confidence The document is a brief correction notice (“訂正”) to a previously published announcement regarding the company’s takeover defense policy. It does not contain substantive financial data, nor is it a full report, but a regulatory announcement correcting units in a prior disclosure. This falls under the general “Regulatory Filings” category (RNS) as a miscellaneous correction announcement.
2026-05-19 Japanese
2026年３月期　決算短信〔日本基準〕（連結）
Earnings Release Classification · 95% confidence The document is a Japanese “決算短信” (earnings release) for the fiscal year ended March 2026 containing summarized consolidated financial results, key financial highlights, dividends, and forecasts. It is not a full annual report (10-K) nor an interim/quarterly report under our definitions, but the initial announcement of annual-period financial results, matching the Earnings Release category. FY 2026
2026-05-11 Japanese
当社株式等の大規模買付行為等への対応方針（買収への対応方針）の導入に関するお知らせ
Governance Information Classification · 90% confidence The document is a notice from the board of directors announcing the adoption of a large‐scale share purchase defense policy (takeover defense plan) under the Japanese Companies Act and related regulations. It details the company’s basic policy on preventing inappropriate control, describes procedures, independent committee setup, information requirements, board evaluation, and shareholder meeting procedures for confirming shareholder intent. This is not a financial report (10-K, IR, ER), not an earnings or capital update, not a proxy solicitation with voting materials, nor an M&A transaction filing. It is a corporate governance document outlining internal rules and governance measures (i.e., a shareholder rights plan). Therefore, the appropriate classification is Governance Information (CGR).
2026-05-11 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification by the CEO of Hoshi Iryo-Sanki Co., Ltd. regarding the accuracy of the contents of the semi-annual report. According to the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a specific report type (like a semi-annual report), should be classified as Regulatory Filings (RNS) rather than the report itself. H1 52
2025-11-12 Japanese
半期報告書－第52期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed by '株式会社星医療酸器' (Hoshi Iryo-Sanki Co., Ltd.) for the period ending September 30, 2025. It contains detailed financial statements, including the balance sheet and management analysis, and is filed under the Financial Instruments and Exchange Act. According to the filing definitions, a comprehensive financial report for a period shorter than a full fiscal year (like a half-year report) containing actual financial statements is classified as an Interim / Quarterly Report (IR). H1 2026
2025-11-12 Japanese
臨時報告書
AGM Information Classification · 100% confidence The document is titled '臨時報告書' (Extraordinary Report) in the header and explicitly states in Section 1 ('提出理由') that it is being submitted based on Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act, following the resolutions made at the Annual General Meeting (AGM) held on June 26, 2025. Section 2 ('報告内容') details the resolutions passed, including the election of directors and auditors, and the results of the shareholder votes (approvals, oppositions, abstentions). This structure—reporting the results of a shareholder meeting—is characteristic of a Declaration of Voting Results & Voting Rights Announcement, which corresponds to the code AGM-R (AGM Information) or DVA (Declaration of Voting Results & Voting Rights Announcements). Since the primary content is the detailed voting results of the AGM, DVA is the most precise fit, although AGM-R is also highly relevant. Given the specific focus on voting outcomes, DVA is selected. The document is a formal filing reporting the outcome of the AGM, not just a presentation (AGM-R) or a proxy solicitation (PSI).
2025-06-26 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.